A study on over 800k adults with type 2 diabetes found that semaglutide and other GLP-1 drugs did not increase or decrease ...

Health officials serving under President Donald Trump want to make it easier for men to get a prescription for testosterone.

Millions worldwide rely on metformin to manage type 2 diabetes, but while generally safe, it can cause rare yet severe side effects. This video details the potential reactions, from common digestive ...

For decades, physicians and scientists have thought that metformin, a biguanide drug that is prescribed for millions of people worldwide for type 2 diabetes (T2D), mainly targets the liver to suppress ...

Long before GLP-1 medications like Ozempic and Mounjaro became both ubiquitous in TV advertisements and the preferred options for treating Type 2 diabetes, doctors often prescribed metformin — a drug ...

The most common side effects of GLP-1 medications like Ozempic and Wegovy are gastrointestinal (GI) issues, including nausea, vomiting, and diarrhea. Those side effects may persist during treatment.

In a sweeping analysis of more than 400,000 Reddit posts, researchers have revealed some little-known GLP-1 side effects. GLP-1 receptor agonists — such as semaglutide (Ozempic and Wegovy), and ...

The Food and Drug Administration issued a warning letter to Novo Nordisk — the maker of Ozempic and Wegovy — for failing to report potential side effects in patients who took its blockbuster ...

Radiotherapy is a key foundation of oncologic treatment that is used across the spectrum of cancer indications. Advances in imaging, treatment planning, and dose delivery have led to increasingly ...

Overall survival in men with metastatic castration-resistant prostate cancer treated with olaparib or lutetium-177-PSMA-617 following prior systemic therapy. Carboplatin in patients with metastatic ...

Credit: Getty Images This literature review supports the use of metformin as an effective and safe treatment alternative to insulin for pregnant women with gestational diabetes. Another option for ...